Article
Gene Repair of iPSC Line with GARS (G294R) Mutation of CMT2D Disease by CRISPR/Cas9.
Current medical science - 1 Apr 2023
Lu Pei-Jie, Zhang Pei, Liu Yu-Chun, Jing Na, Guo Ya-Nan, Wang Peng-Shuai, Su Lin-Lin, Guo Qi, Ma Qiang, Xu Yu-Ming, Zhang Shou-Tao
Abstract excerpt
OBJECTIVE: Charcot-Marie-Tooth disease (CMT) severely affects patient activity, and may cause disability. However, no clinical treatment is available to reverse the disease course. The combination of CRISPR/Cas9 and iPSCs may have therapeutic potential against nervous diseases, such as CMT. METHODS: In the present study, the skin fibroblasts of CMT type 2D (CMT2D) patients with the c.880G>A heterozygous...
Topics
Join the communities discussing this publication.
